Past-futures in experimental care: breast cancer and HIV medicine

References

• Academy of Medical Sciences. 2015. “Stratified, Personalised or P4 Medicine: A New Direction for Placing the Patient at the Centre of Healthcare and Health Education (May 2015).” Accessed March 5 2019. https://acmedsci.ac.uk/download?f=file&i=32644.
   Google Scholar
• Adams, Vincanne, Michelle Murphy, and Adele E Clarke. 2009. “Anticipation: Technoscience, Life, Affect, Temporality.” Subjectivity 28 (1): 246–265.
   Google Scholar
• Arteaga, Carlos L., Mark X Sliwkowski, C. Kent Osborne, Edith A. Perez, Fabio Puglisi, and Luca Gianni. 2012. “Treatment of HER2-Positive Breast Cancer: Current Status and Future Perspectives.” Nature Reviews Clinical Oncology 9 (1): 16–32. doi:https://doi.org/10.1038/nrclinonc.2011.177.
   Web of Science ®Google Scholar
• Baylis, Alex, David Buck, Jane Anderson, Joni Jabbal, and Shilpa Ross. 2017. The Future of HIV Services in England. London: Kings Fund.
   Google Scholar
• Beckmann, Nadine. 2013. “Responding to Medical Crises: AIDS Treatment, Responsibilisation and the Logic of Choice.” Anthropology & Medicine 20 (2): 160–174.
   PubMed Web of Science ®Google Scholar
• Berridge, Virginia. 2002. “AIDS and the Rise of the Patient? Activist Organisation and HIV/AIDS in the UK in the 1980s and 1990s.” Medizin, Gesellschaft, und Geschichte: Jahrbuch des Instituts fur Geschichte der Medizin der Robert Bosch Stiftung 21: 109–123.
   PubMedGoogle Scholar
• Berridge, Virginia, and Phillip Strong, eds. 1993. AIDS and Contemporary History. Cambridge: Cambridge University Press.
   Google Scholar
• Bourret, Pascale, and Alberto Cambrosio. 2019. “Genomic Expertise in Action: Molecular Tumour Boards and Decision-Making in Precision Oncology.” Sociology of Health and Illness 41 (8): 1568–1584.
   PubMed Web of Science ®Google Scholar
• Bowker, Geoffrey C., and Susan Leigh Star. 1999. Sorting Things Out: Classification and Its Consequences. Cambridge, MA: MIT Press.
   Google Scholar
• Brenton, James D., Lisa A. Carey, Ahmed Ashour Ahmed, and Carlos Caldas. 2005. “Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?” Journal of Clinical Oncology 23: 7350–7360.
   PubMed Web of Science ®Google Scholar
• Brown, Nik. 2003. “Hope Against Hype - Accountability in Biopasts, Presents and Futures.” Science & Technology Studies 16 (2). https://sciencetechnologystudies.journal.fi/article/view/55152.
   Google Scholar
• Brown, Nik, and Mike Michael. 2003. “A Sociology of Expectations: Retrospecting Prospects and Prospecting Retrospects.” Technology Analysis and Strategic Management 15 (1): 3–18.
   Web of Science ®Google Scholar
• Bruton, Jane, Tanvi Rai, Sophie Day and Helen Ward. 2018. “Patient Perspectives on the HIV Continuum of Care in London: A Qualitative Study of People Diagnosed Between 1986 and 2014.” BMJ Open 8 (3): 1–7.
   Web of Science ®Google Scholar
• Bryder, Linda. 2014. “The Medical Research Council and Treatments for Tuberculosis Before Streptomycin.” JLL Bulletin: Commentaries on the History of Treatment Evaluation. Accessed March 5 2019. http://www.jameslindlibrary.org/articles/the-medical-research-council-and-treatments-for-tuberculosis-before-streptomycin.
   Google Scholar
• Callard, Felicity, and Des Fitzgerald. 2015. Rethinking Interdisciplinarity across the Social Sciences and Neurosciences. Basingstoke: Palgrave Macmillan.
   Google Scholar
• Cambrosio, Alberto, Peter Keating, Etienne Vignola-Gagné, Sylvain Besle, and Pascale Bourret. 2018. “Extending Experimentation: Oncology’s Fading Boundary Between Research and Care.” New Genetics and Society 37 (3): 207–226.
   Web of Science ®Google Scholar
• Chadwick, Ruth. 2017. “What's in a name: conceptions of personalized medicine and their ethical implications.” Lato Sensu, Revue de la Société de Philosophie des Sciences 4 (2): 5–11.
   Google Scholar
• Chalmers, Iain. 2013. “UK Medical Research Council and Multicentre Clinical Trials: From a Damning Report to International Recognition.” JLL Bulletin: Commentaries on the History of Treatment Evaluation. Accessed March 5 2019. http://www.jameslindlibrary.org/articles/uk-medical-research-council-and-multicentre-clinical-trials-from-a-damning-report-to-international-recognition.
   Google Scholar
• Cohrs, Randall J., Tyler Martin, Parviz Ghahramani, Luc Bidaut, Paul J. Higgins, and Aamir Shahzad. 2014. “Translational Medicine Definition by the European Society for Translational Medicine.” European Journal of Molecular and Clinical Medicine 2 (3): 86–88.
   Google Scholar
• Colvin, Christopher J. 2014. “Evidence and AIDS Activism: HIV Scale-up and the Contemporary Politics of Knowledge in Global Public Health.” Global Public Health 9 (1–2): 57–72.
   PubMed Web of Science ®Google Scholar
• Concorde Coordinating Committee. 1994. “Concorde: MRC/ANRS Randomised Double-Blind Controlled Trial of Immediate and Deferred Zidovudine in Symptom-Free HIV Infection.” Lancet 343: 871–881.
   PubMed Web of Science ®Google Scholar
• Connor, Steven. 2003. “Glaxo Chief: Our Drugs Do Not Work On Most Patients.” Accessed 14 November 2019. https://www.independent.co.uk/news/science/glaxo-chief-our-drugs-do-not-work-on-most-patients-5508670.html.
   Google Scholar
• Coombes, Raoul Charles, Karen Page, Raheleh Salari, Robert K Hastings, Anne Armstrong, Samreen Ahmed, Simak Ali, et al. 2019. “Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.” Clinical Cancer Research 25 (14): 4255–4263.
   PubMed Web of Science ®Google Scholar
• Crabu, Stefano. 2018. “Rethinking Biomedicine in the Age of Translational Research: Organisational, Professional, and Epistemic Encounters.” Sociology Compass August: e12623. doi:https://doi.org/10.1111/soc4.12623.
   Google Scholar
• Curtis, Christina, Sohrab P Shah, Suet-Feung Chin, Gulisa Turashvili, Oscar M Rueda, Mark J Dunning, Doug Speed, et al. 2012. “The Genomic and Transcriptomic Architecture of 2,000 Breast Tumours Reveals Novel Subgroups.” Nature 486 (7403): 346–352. doi:https://doi.org/10.1038/nature10983.
   PubMed Web of Science ®Google Scholar
• Davies, Sally. 2017. Chief Medical Officer Annual Report 2016: Generation Genome. London: Department of Health and Social Care.
   Google Scholar
• Day, Sophie, R. Charles Coombes, Louise McGrath-Lone, Claudia Schoenborn, and Helen Ward. 2016. “Stratified, Precision or Personalised Medicine? Cancer Services in the “Real World” of a London Hospital.” Sociology of Health and Illness 39 (1): 143–158.
   PubMed Web of Science ®Google Scholar
• Department of Health. 1989. Working for Patients. London: HMSO.
   Google Scholar
• Dickenson, Donna. 2011. Me Medicine Vs. We Medicine: Reclaiming Biotechnology for the Common Good. New York: Columbia University Press.
   Google Scholar
• Dumit, Joseph. 2012. Drugs for Life: How Pharmaceutical Companies Define Our Health. Durham, NC and London: Duke University Press.
   Google Scholar
• Elbaz, Gilbert. 1995. “Beyond Anger: The Activist Construction of the AIDS Crisis.” Social Justice 22 (62): 43–76.
   Google Scholar
• Epstein, Steven. 1996. Impure Science: AIDS, Activism and the Politics of Knowledge. London: University of California Press.
   Google Scholar
• Erikainen, Sonja, and Sarah Chan. 2019. “Contested Futures: Envisioning ‘Personalized,’ ‘Stratified,’ and ‘Precision’ Medicine.” New Genetics and Society 38 (3): 308–330.
   PubMed Web of Science ®Google Scholar
• Fairbrother, Greg, Chiarella Mary, and Braithwaite Jeffrey. 2015. “Models of Care Choices in Today’s Nursing Workplace: Where Does Team Nursing Sit.” Australian Health Review 39: 489–493.
   PubMed Web of Science ®Google Scholar
• Feiler, Therese, Kezia Gaitskell, Tim Maughan, and Joshua Hordern. 2017. “Personalised Medicine: The Promise, the Hype and the Pitfalls.” The New Bioethics 23 (1): 1–12.
   PubMed Web of Science ®Google Scholar
• Flores, Mauricio, Gustavo Glusman, Kristin Brogaard, Nathan D Price, and Leroy Hood. 2013. “P4 Medicine: How Systems Medicine Will Transform the Healthcare Sector and Society.” Personalized Medicine 10 (6): 565–576.
   PubMed Web of Science ®Google Scholar
• Flynn, Rob. 2012. Structures of Control in Health Management. London: Routledge.
   Google Scholar
• Fortun, Michael A. 2008. Promising Genomics Iceland and deCODE Genetics in a World of Speculation. Los Angeles, CA: University of California Press.
   Google Scholar
• Gabe, Jonathan, Kerry Chamberlain, Pauline Norris, Kevin Dew, Helen Madden, and Darrin Hodgetts. 2012. “The Debate About the Funding of Herceptin: A Case Study of ‘Countervailing Powers.” Social Science and Medicine 75 (12): 2353–2361.
   PubMed Web of Science ®Google Scholar
• Galison, Peter. 1987. How Experiments End. Chicago: University of Chicago Press.
   Google Scholar
• General Medical Council. 2010. “Good Practice in Research.” Accessed May 29 2019. https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/good-practice-in-research.
   Google Scholar
• Genomics England. “The UK Has Sequenced 1000 Whole Genomes in the NHS.” Accessed December 18 2018 https://www.genomicsengland.co.uk/the-uk-has-sequenced-100000-whole-genomes-in-the-nhs/, https://www.england.nhs.uk/genomics/nhs-genomic-med-service/.
   Google Scholar
• Haase, Rachel, Marsha Michie, and Debra Skinner. 2015. “Flexible Positions, Managed Hopes: The Promissory Bioeconomy of a Whole Genome Sequencing Cancer Study.” Social Science and Medicine 130: 146–153.
   PubMed Web of Science ®Google Scholar
• Hacking, Ian. 1983. Representing and Intervening: Introductory Topics in the Philosophy of Natural Science. Cambridge: Cambridge University Press.
   Google Scholar
• Hallowell, N., S. Cooke, G. Crawford, A. Lucassen, M. Parker, and C. Snowdon. 2010. “An Investigation of Patients’ Motivations for Their Participation in Genetics-Related Research.” Journal of Medical Ethics 36 (1): 37–45.
   PubMed Web of Science ®Google Scholar
• Hayes, Richard J., Deborah J. Donnell, Sian Floyd, Nomtha Mandla, Justin Bwalya, Kwame Shanaube, Ayana Moore, et al. 2019. “Impact of Universal Testing and Treatment in Zambia and South Africa: HPTN 071 (PopART).” Oral presentation at the Conference on Retroviruses and Opportunistic Infections (CROI), Seattle.
   Google Scholar
• Hedgecoe, Adam. 2004. The Politics of Personalised Medicine: Pharmacogenetics in the Clinic. Cambridge University Press.
   Google Scholar
• Hedgecoe, Adam, and Paul Martin. 2003. “The Drugs Don’t Work: Expectations and the Shaping of Pharmacogenetics.” Social Studies of Science 33 (3): 327–364.
   PubMed Web of Science ®Google Scholar
• Hildebrandt, Timothy, Leticia Bode, and Jessica S. C. Ng. 2019. “Responsibilization and Sexual Stigma Under Austerity: Surveying Public Support for Government-Funded PrEP in England.” Sexuality Research and Social Policy. doi:https://doi.org/10.1007/s13178-019-00422-z.
   Google Scholar
• Hood, Leroy, and Stephen H. Friend. 2011. “Predictive, Personalized, Preventive, Participatory (P4) Cancer Medicine.” Nature Reviews Clinical Oncology 8: 184–187.
   PubMed Web of Science ®Google Scholar
• Institute of Medical Ethics Working Party. 1992. “AIDS, Ethics, and Clinical Trials.” British Medical Journal 305: 699–701.
   PubMedGoogle Scholar
• Keating, Peter, and Alberto Cambrosio. 2011. Cancer on Trial: Oncology as a New Style of Practice. Chicago, IL: University of Chicago Press.
   Google Scholar
• Keating, Peter, and Alberto Cambrosio. 2012. “Cancer Research and Protocol Patients: From Clinical Material To Committee Advisors.” In Cancer Patients, Cancer Pathways: Historical and Sociological Perspectives, edited by Carsten Timmerman, and Elizabeth Toon, 161–185. London: Palgrave Macmillan.
   Google Scholar
• Keogh, Bruce. 2015. Personalised Medicine Strategy. London: NHS England Paper. PB.24.09.15/05. Accessed 14 November 2019. https://www.england.nhs.uk/wp-content/uploads/2015/09/item5-board-29-09-15.pdf.
   Google Scholar
• Kerr, Anne, Julia Swallow, Choon Key Chekar, and Sarah Cunningham-Burley. 2019. “Genomic Research and the Cancer Clinic: Uncertainty and Expectations in Professional Accounts.” New Genetics and Society 38 (2): 222–239.
   PubMed Web of Science ®Google Scholar
• Kost, Rhonda G, Laura M. Lee, Jennifer Yessis, Barry S. Coller, and David K. Henderson, and The Research Participant Perception Survey Focus Group Subcommittee. 2011. “Assessing Research Participants’ Perceptions of Their Clinical Research Experiences.” Clinical and Translational Science 4 (6): 403–413.
   PubMed Web of Science ®Google Scholar
• The Lancet. 2015. “HIV: The Question is Not When to Treat, But How to Treat.” The Lancet 386 (10002): 1420.
   Web of Science ®Google Scholar
• Le Grand, Julian. 1991. “Quasi-markets and Social Policy.” The Economic Journal 101 (408): 1256–1267.
   Web of Science ®Google Scholar
• Mallal, Simon, Elizabeth Phillips, Giampiero Carosi, Jean-Michel Molina, Cassy Workman, Janez Tomažič, Eva Jägel-Guedes, et al. 2008. “HLA-B*5701 Screening for Hypersensitivity to Abacavir.” New England Journal of Medicine 358 (6): 568–579. doi:https://doi.org/10.1056/NEJMoa0706135.
   PubMed Web of Science ®Google Scholar
• Marra, Antonio, Giulia Viale, and Giuseppe Curigliano. 2019. “Recent Advances in Triple Negative Breast Cancer: The Immunotherapy Era.” BMC Medicine 17: 90.
   PubMed Web of Science ®Google Scholar
• Martin, Paul, Nik Brown, and Andrew Turner. 2008. “Capitalizing Hope: The Commercial Development Of Umbilical Cord Blood Stem Cell Banking.” New Genetics and Society 27 (2): 127–143.
   Web of Science ®Google Scholar
• Matthews, Philippa, Sara Madge, Surinder Singh, and Nick Theobald. 2016. HIV in Primary Care: A Practical Guide for Primary Healthcare Professionals in Europe. 3rd ed. London: MEDFASH.
   Google Scholar
• Maughan, Tim. 2017. “The Promise and the Hype of ‘Personalised Medicine.” The New Bioethics 23 (1): 13–20.
   PubMed Web of Science ®Google Scholar
• Mc Grath-Lone, Louise, Sophie Day, Claudia Schoenborn, and Helen Ward. 2015. “Exploring Research Participation Among Cancer Patients: Analysis of a National Survey and an In-Depth Interview Study.” BMC Cancer 15: 618.
   PubMed Web of Science ®Google Scholar
• Mc Grath-Lone, Louise, Helen Ward, Claudia Schoenborn, and Sophie Day. 2016. “The Effects of Cancer Research Participation on Patient Experience: A Mixed-Methods Analysis.” European Journal of Cancer Care 25 (6): 1056–1064.
   PubMed Web of Science ®Google Scholar
• Merigan, T. C. 1990. “You Can Teach An Old Dog New Tricks: How AIDS Trials are Pioneering New Strategies.” New England Journal of Medicine 323: 1341–1343.
   PubMed Web of Science ®Google Scholar
• Mistry, Pankaj, Janet A. Dunn, and Andrea Marshall. 2017. “A Literature Review of Applied Adaptive Design Methodology Within the Field of Oncology In Randomised Controlled Trials and a Proposed Extension to the CONSORT Guidelines.” BMC Medical Research Methodology 17: 108.
   PubMed Web of Science ®Google Scholar
• Mittra, James, and Christopher-Paul Milne. 2013. Translational Medicine: The Future of Therapy? Singapore: PanStanford.
   Google Scholar
• Mol, Annamarie. 2008. The Logic of Care: Health and the Problem of Patient Choice. London: Routledge.
   Google Scholar
• Mold, Alex. 2010. “Patient Groups and the Construction of the Patient Consumer in Britain: An Historical Overview.” Journal of Social Policy 39: 505–521.
   PubMed Web of Science ®Google Scholar
• National Health Service (NHS) England. 2015. “Gearing Up for one of the Most Fundamental Changes in NHS History.” Accessed March 5 2019. https://www.england.nhs.uk/2015/09/personalised-medicine/.
   Google Scholar
• National Health Service (NHS) England. 2016. Improving Outcomes through Personalised Medicine: Working at the Cutting Edge of Science to Improve Patients’ Lives. Accessed March 5 2019. https://www.england.nhs.uk/wp-content/uploads/2016/09/improving-outcomes-personalised-medicine.pdf.
   Google Scholar
• National Health Service (NHS) England. 2019. The NHS Long Term Plan. Accessed 14 November 2019. https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf.
   Google Scholar
• National Health Service (NHS) England. N.d. “NHS Genomic Medicine Service.” Accessed December 18 2018. https://www.england.nhs.uk/genomics/nhs-genomic-med-service/.
   Google Scholar
• Nicholls, Emily Jay, and Marta Rosengarten. 2019. Witness Seminar: Antiretroviral Drugs up to and Including the Proposition of TasP and PrEP. Disentangling European HIV/AIDS Policies: Activism, Citizenship and Health (EUROPACH).
   Google Scholar
• The Nuffield Council on Bioethics. 2018. “Patient Access to Experimental Treatments.” Accessed May 24 2019. http://nuffieldbioethics.org/wp-content/uploads/Patient-access-to-experimental-treatments.pdf.
   Google Scholar
• Padamsee, Tasleem J. 2020. “Fighting an Epidemic in Political Context: Thirty-Five Years of HIV/AIDS Policy Making in the United States.” Social History of Medicine 33 (3): 1001–1028.
   PubMed Web of Science ®Google Scholar
• Panofsky, Aaron. 2010. “Generating Sociability to Drive Science: Patient Advocacy Organizations and Genetics Research.” Social Studies of Science 41 (1): 31–57.
   Web of Science ®Google Scholar
• Pareja, Fresia, Felipe C. Geyer, Caterina Marchiò, Kathleen A Burke, Britta Weigelt, and Jorge S. Reis-Filho. 2016. “Triple-Negative Breast Cancer: The Importance of Molecular and Histologic Subtyping, and Recognition Of Low-Grade Variants.” NPJ Breast Cancer 2: 16036.
   PubMed Web of Science ®Google Scholar
• Pokorska-Bocci, Anna, Alison Stewart, Gurdeep S Sagoo, Alison Hall, Mark Kroese, and Hilary Burton. 2014. “‘Personalized Medicine’: What’s in a Name?” Personalized Medicine 11 (2): 197–210.
   PubMed Web of Science ®Google Scholar
• Prainsack, Barbara. 2017. Personalized Medicine: Empowered Patients in the 21st Century? New York, NY: New York University Press.
   Google Scholar
• Prasad, Vinay. 2016. “Perspective: The Precision-Oncology Illusion.” Nature 537: S63.
   PubMed Web of Science ®Google Scholar
• Rai, Tanvi, Jane Bruton, Sophie Day, and Helen Ward. 2018. “From Activism to Secrecy: Contemporary Experiences of Living with HIV in London in People Diagnosed from 1986 to 2014.” Health Expectations 21: 1134–1141.
   PubMed Web of Science ®Google Scholar
• Rai, Tanvi, Jane Bruton, Meaghan Kall, Richard Ma, Erica L. Pufall, Sophie Day, Vau Delpech, and Helen Ward. 2019. “Re-thinking Care for People with HIV: A Mixed Methods Study of Disclosure, Utilisation and Satisfaction with GP Services in the UK.” BJGP Open 10 (3(4)): bjgpopen19X101665.
   Google Scholar
• Rajan, Kaushik Sunder. 2006. Biocapital: The Constitution of Postgenomic Life. Durham, NC: Duke University Press.
   Google Scholar
• Rajan, Kaushik Sunder. 2017. Pharmocracy: Value, Politics, and Knowledge in Global Biomedicine. Durham, NC: Duke University Press.
   Google Scholar
• Rheinberger, Hans-Jörg. 1997. Toward a History of Epistemic Things. Paolo Alto, CA: Stanford University. Press.
   Google Scholar
• Rheinberger, Hans-Jörg. 2010. An Epistemology of the Concrete: Twentieth-Century Histories of Life. Durham, NC: Duke University Press.
   Google Scholar
• Richardson, Sarah S., and Hallam Stevens, eds. 2015. Postgenomics: Perspectives on Biology After the Genome. Durham, NC: Duke University Press.
   Google Scholar
• Roepstorff, Andreas, and Chris Frith. 2012. “Neuroanthropology or Simply Anthropology? Going Experimental as Method, as Object of Study, and as Research Aesthetic.” Anthropological Theory 12 (1): 101–111.
   Web of Science ®Google Scholar
• Rueda, Oscar M, Stephen-John Sammut, Jose A. Seoane, Suet-Feung Chin, Jennifer L. Caswell-Jin, Maurizio Callari, Rajbir Batra, et al. 2019. “Dynamics of Breast-Cancer Relapse Reveal Late-Recurring ER-Positive Genomic Subgroups.” Nature 567 (7748): 399–404.
   PubMed Web of Science ®Google Scholar
• Rushforth, Alex, and Trisha Greenhalgh. 2020. “Personalized Medicine, Disruptive Innovation, and ‘Trailblazer’ Guidelines: Case Study and Theorization of an Unsuccessful Change Effort.” The Milbank Quarterly n/a (n/a).
   Google Scholar
• Sacristán, José A, and Tatiana Dilla. 2018. “Pragmatic Trials Revisited: Applicability Is About Individualization.” Journal of Clinical Epidemiology 99: 164–166.
   PubMed Web of Science ®Google Scholar
• Schleidgen, Sebastian, Corinna Klingler, Teresa Bertram, Wolf H Rogowski, and Georg Marckmann. 2013. “What Is Personalized Medicine: Sharpening a Vague Term Based on a Systematic Literature Review.” BMC Medical Ethics 14 (1): 55. doi:https://doi.org/10.1186/1472-6939-14-55.
   PubMedGoogle Scholar
• Schmid, Peter, Sylvia Adams, Hope S Rugo, Andreas Schneeweiss, Carlos H. Barrios, Hiroji Iwata, Véronique Diéras, et al. 2018. “Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.” New England Journal of Medicine 379 (22): 2108–2121.
   PubMed Web of Science ®Google Scholar
• Shilts, Randy. 1987. And the Band Played On: Politics, People and the AIDS Epidemic. New York: St Martin’s Press.
   Google Scholar
• Sobhani, Navid, Alberto D’Angelo, Matteo Pittacolo, Giandomenico Roviello, Anna Miccoli, Silvia Paola Corona, Ottavia Bernocchi, Daniele Generali, and Tobias Otto. 2019. “Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer.” Cells 8 (4): 321.
   Web of Science ®Google Scholar
• Sturdy, Steve. 2017. “Personalised Medicine and the Economy of Biotechnological Promise.” New Bioethics 23 (1): 30–37.
   PubMed Web of Science ®Google Scholar
• Swallow, Julia, Anne Kerr, Choon Key Chekar, and Sarah Cunningham-Burley. 2020. “Accomplishing an Adaptive Clinical Trial for Cancer: Valuation Practices and Care Work across the Laboratory and the Clinic.” Social Science & Medicine 252: 112949.
   PubMed Web of Science ®Google Scholar
• Taussig, Karen-Sue, Klaus Hoeyer, and Stefan Helmreich. 2013. “An Introduction to Supplement 7.” Current Anthropology 54 (S7): S3–14. doi:https://doi.org/10.1086/671401.
   Google Scholar
• Timmermans, Stefan, and Marc Berg. 1997. “Standardization in Action: Achieving Local Universality through Medical Protocols.” Social Studies of Science 27 (2): 273–305.
   Web of Science ®Google Scholar
• Tutton, Richard. 2012. “Personalizing Medicine: Futures Present and Past.” Social Science and Medicine 75 (10): 1721–1728.
   PubMed Web of Science ®Google Scholar
• Tutton, Richard. 2014. Genomics and the Reimagining of Personalized Medicine. Farnham: Ashgate Publishing Ltd.
   Google Scholar
• U.S. Department of Health and Human Services Food and Drug Administration. 2018. “Adaptive Designs for Clinical Trials of Drugs and Biologics Guidance for Industry.” Accessed June 13 2019. https://www.fda.gov/media/78495/download.
   Google Scholar
• Vecchio, Good, Mary-Jo del, Byron J Good, Cynthia Schaffer, and Stuart E Lind. 1990. “American Oncology and the Discourse on Hope.” Culture, Medicine and Psychiatry 14 (1): 59–79.
   PubMed Web of Science ®Google Scholar
• Weber, Jonathan. 2018. “Working with HIV/AIDS Patients Was the Highlight of my Clinical Career.” Accessed March 5 2019. https://www.imperial.nhs.uk/about-us/blog/prof-jonathan-weber-working-with-hiv-aids-patients.
   Google Scholar
• World Health Organization. WHO and UNAIDS. 2006. Progress on Global Access to HIV Antiretroviral Therapy: A Report to “3 by 5″ and Beyond. Geneva: WHO.
   Google Scholar